Clinical Trial Update: Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma [Phase 2]

View source ↗

Summary

A Phase II multicenter trial evaluating oral digoxin for Kaposi's sarcoma, including classic and endemic forms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• DIGOXIN (Digoxin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Kaposi' s Sarcoma, Classic Kaposi' s Sarcoma | Phase 2 | Status: UNKNOWN